Patent · US Active

Enzyme treatment of glucans

US8252295B2 · kind B2 · utility

0Cited by

14References

9Claims

0Family size

Inventors

Rolf Engstad · Tromsø, NO
Finn Kortner · Tromsø, NO
Borre Robertsen · Tromsø, NO
Gunnar Rorstad · Tromsø, NO

Key dates

Filing date	Dec 27, 2010
Grant date	Aug 28, 2012
Priority date	—
Expiry date	Dec 27, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/55511
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

β-(1-6)-Glucanese treatment of glucan from yeast cells, pure or feed grade, especially yeast from the family Saccharomyces and particularly Saccharomyces cerevisiae, provides a novel glucan product suitable for use in enhancing the stimulation of host animal immune systems. Solubilization of such yeast cell glucan is further disclosed to extend the usefulness of yeast cell glucan as an adjuvant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.